GO:1903980 positive regulation of microglial cell activation: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903980 describes any biological process that increases the frequency, rate, or extent of microglial cell activation, a central event in neuroinflammation and brain homeostasis [1, 5].
• Key molecular drivers include metabolic reprogramming via histone H4 lysine 12 lactylation, which creates a positive feedback loop sustaining microglial glucose metabolism and activation in Alzheimer's disease.
• The HMGB1/STAT3/p65 axis drives microglial activation and autophagy in chronic stress-induced major depressive disorder, linking danger signals to transcriptional activation.
• TRIM45 aggravates microglial pyroptosis through the Atg5/NLRP3 axis in septic encephalopathy, illustrating how positive regulation can tip toward pathological inflammation.
• Therapeutic modulation of microglial activation states, such as shifting M1/M2 polarization via STAT1/STAT6/PPARγ, is a validated strategy to reduce inflammation in neurological disease models [4, 8].
• Astrocyte-derived factors and microbial metabolites can control microglial activation, revealing intercellular circuits that fine-tune neuroinflammatory responses [3, 5].
Description
Microglial cells are the resident macrophages of the central nervous system and act as the first line of defense against injury and infection. Their activation is a tightly regulated process that can be beneficial for tissue repair or detrimental when excessive or chronic. The Gene Ontology term GO:1903980, positive regulation of microglial cell activation, captures any process that increases the frequency, rate, or extent of this activation state [1, 5]. Understanding this term is critical because dysregulated microglial activation is a common denominator in neurodegenerative, neuropsychiatric, and neuroinflammatory disorders [1, 2, 7]. Research over the past decade has identified diverse molecular triggers that positively regulate microglial activation, including metabolic shifts, danger-associated molecular patterns, and cytokine signaling. For example, histone H4 lysine 12 lactylation sustains a positive feedback loop that reinforces microglial glucose metabolism and pro-inflammatory activation in Alzheimer's disease models. Similarly, the HMGB1/STAT3/p65 axis drives microglial activation and autophagy under chronic stress, contributing to major depressive disorder-like behaviors. These findings highlight that positive regulation is not a single pathway but a convergence of metabolic, epigenetic, and immune signaling events. For researchers, GO:1903980 provides a framework to annotate genes and pathways that amplify microglial responses. It is distinct from negative regulation (GO:1903981) and from the core activation process itself. By studying positive regulators, scientists can identify therapeutic targets to dampen harmful neuroinflammation while preserving beneficial microglial functions [4, 6, 8].
positive regulation of microglial cell activation At A Glance
| GO ID | GO:1903980 |
|---|---|
| GO term | positive regulation of microglial cell activation |
| Ontology | biological_process |
| Synonym | activation of microglial cell activation; up regulation of microglial cell activation; up-regulation of microglial cell activation; upregulation of microglial cell activation |
| Major function | Increases the frequency, rate, or extent of microglial cell activation, a key step in neuroinflammation and immune surveillance. |
| Related processes | Microglial activation, neuroinflammation, immune response, cytokine production, phagocytosis. |
| Cellular context | Microglia in the central nervous system, including brain and spinal cord. |
| Disease relevance | Alzheimer's disease, major depressive disorder, septic encephalopathy, ischemic stroke, multiple sclerosis. |
What Is GO:1903980?
GO:1903980, positive regulation of microglial cell activation, is defined as any process that activates or increases the frequency, rate, or extent of microglial cell activation. In other words, it encompasses all molecular and cellular events that push microglia toward an activated state, whether that activation is protective or pathological. This term is a child of positive regulation of immune system process and is specific to microglial cells, distinguishing it from general macrophage activation.
Why Is positive regulation of microglial cell activation Important in Cell Biology?
Positive regulation of microglial cell activation is a double-edged sword in the central nervous system. On one hand, timely activation is essential for clearing pathogens, removing debris, and promoting tissue repair after injury. On the other hand, excessive or sustained activation drives chronic neuroinflammation, which contributes to the pathogenesis of neurodegenerative diseases such as Alzheimer's disease, neuropsychiatric disorders like major depressive disorder, and acute conditions such as septic encephalopathy and ischemic stroke [1, 2, 6, 7]. Understanding the molecular players that positively regulate this process is therefore critical for developing therapies that can selectively modulate microglial activity without compromising essential immune functions.
• Central to neuroinflammation, a hallmark of many neurological and psychiatric disorders [1, 7].
• Drives metabolic reprogramming in microglia, linking cellular metabolism to immune activation.
• Involved in the pathogenesis of Alzheimer's disease through sustained pro-inflammatory loops.
• Contributes to major depressive disorder via chronic stress-induced HMGB1/STAT3/p65 signaling.
• Aggravates septic encephalopathy through TRIM45-mediated pyroptosis.
• Modulates outcomes after ischemic stroke by influencing T cell recruitment.
• Can be targeted by anti-inflammatory agents such as aloe-emodin to reduce ischemia-reperfusion injury.
• Intercellular communication with astrocytes and microbial metabolites fine-tunes microglial activation [3, 5].
• Provides a framework for annotating genes that amplify or dampen neuroinflammation.
• Offers therapeutic opportunities to shift microglial polarization from M1 to M2 phenotypes [4, 8].
What Happens During positive regulation of microglial cell activation?
Initiation by danger signals and metabolic cues
In simple terms: Microglia sense danger molecules and metabolic changes that tell them to wake up and become active.
Positive regulation of microglial activation often begins with the detection of danger-associated molecular patterns (DAMPs) such as HMGB1, or with metabolic shifts in the brain microenvironment. In chronic stress models, HMGB1 activates the STAT3/p65 axis, which drives microglial activation and autophagy, contributing to depressive-like behaviors. Similarly, in Alzheimer's disease, metabolic reprogramming via histone H4 lysine 12 lactylation creates a positive feedback loop that sustains microglial glucose metabolism and pro-inflammatory activation. These initial signals converge on transcriptional programs that upregulate activation markers and inflammatory mediators.
Transcriptional and epigenetic amplification
In simple terms: Once triggered, microglia turn on genes that keep them activated through changes in DNA packaging and transcription factors.
Activation is reinforced by epigenetic modifications and transcription factor networks. Histone H4 lysine 12 lactylation directly promotes the expression of genes involved in glucose metabolism and inflammatory responses, establishing a self-reinforcing loop in Alzheimer's disease microglia. The STAT3/p65 pathway also induces a broad transcriptional program that includes autophagy-related genes, further amplifying the activated state. These mechanisms ensure that once microglia are activated, they remain responsive to ongoing stimuli.
Inflammasome activation and pyroptosis
In simple terms: Activated microglia can trigger an inflammatory cell death program called pyroptosis, which releases more inflammatory signals.
Positive regulation can escalate to pyroptosis, a lytic form of cell death. In septic encephalopathy, TRIM45 aggravates microglial pyroptosis via the Atg5/NLRP3 axis, linking autophagy dysregulation to inflammasome activation. Similarly, in cerebral ischemia-reperfusion injury, NLRP3 inflammasome activation promotes microglial pyroptosis and polarization toward a pro-inflammatory phenotype, which can be alleviated by aloe-emodin. This step represents a point of no return where microglial activation becomes highly destructive.
Intercellular crosstalk with astrocytes and T cells
In simple terms: Activated microglia talk to other brain cells, like astrocytes and T cells, to coordinate or amplify inflammation.
Microglial activation is modulated by signals from astrocytes and peripheral immune cells. Astrocytes can release factors that either promote or restrain microglial reactivity, and a molecular switch for neuroprotective astrocyte reactivity has been described. Microbial metabolites can also control microglial responses, which in turn influence astrocytes. In acute ischemic stroke, microglial LILRB4 upregulation reduces brain damage by limiting CD8+ T cell recruitment, showing that positive regulation of microglial activation can also have protective, anti-inflammatory consequences depending on context.
Resolution or chronic persistence
In simple terms: Ideally, microglial activation resolves, but if the trigger persists, it becomes chronic and harmful.
Under normal conditions, positive regulation is transient and gives way to resolution. However, when danger signals persist, as in chronic neurodegeneration or stress, microglia remain in an activated state. Therapeutic strategies aim to shift microglia from a pro-inflammatory M1-like phenotype to an anti-inflammatory M2-like phenotype. For example, ultrasound has been shown to reduce inflammation by modulating M1/M2 polarization through STAT1/STAT6/PPARγ signaling pathways. Similarly, aloe-emodin promotes M2 polarization and inhibits pyroptosis in ischemia-reperfusion injury. Understanding how to promote resolution is a major research goal.
Key Genes Involved in GO:1903980 positive regulation of microglial cell activation
The following genes and proteins are experimentally validated participants in positive regulation of microglial cell activation, as reported in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HMGB1 | DAMP that activates STAT3/p65 signaling | Drives microglial activation in chronic stress-induced depression |
| STAT3 | Transcription factor downstream of HMGB1 | Mediates microglial activation and autophagy |
| p65 (RELA) | NF-κB subunit, transcription factor | Part of HMGB1/STAT3/p65 axis promoting activation |
| TRIM45 | E3 ubiquitin ligase | Aggravates microglial pyroptosis via Atg5/NLRP3 axis in septic encephalopathy |
| Atg5 | Autophagy-related protein | Involved in TRIM45-mediated pyroptosis |
| NLRP3 | Inflammasome sensor | Mediates pyroptosis and IL-1β release in activated microglia [2, 8] |
| LILRB4 | Inhibitory receptor | Upregulation reduces brain damage by limiting CD8+ T cell recruitment after stroke |
| STAT1 | Transcription factor for M1 polarization | Promotes pro-inflammatory microglial activation |
| STAT6 | Transcription factor for M2 polarization | Promotes anti-inflammatory microglial activation |
| PPARγ | Nuclear receptor | Modulates M1/M2 polarization, anti-inflammatory |
| H4K12la | Histone modification (lactylation) | Sustains microglial glucose metabolism and activation in Alzheimer's disease |
| CD8+ T cells | Peripheral immune cells | Recruited by activated microglia, contribute to stroke damage |
| Astrocyte-derived factors | Intercellular signals | Modulate microglial reactivity and neuroprotection |
| Microbial metabolites | Host-microbe interaction molecules | Control microglial responses and astrocyte function |
How Is positive regulation of microglial cell activation Regulated?
Positive regulation of microglial cell activation is controlled at multiple levels. Epigenetically, histone lactylation creates a positive feedback loop that reinforces metabolic and inflammatory gene expression. Transcriptionally, the HMGB1/STAT3/p65 axis drives a broad activation program. Post-translationally, E3 ligases such as TRIM45 modulate autophagy and inflammasome activity. Intercellularly, astrocytes and microbial metabolites provide external cues that can either amplify or dampen microglial activation [3, 5]. Finally, therapeutic modulation of STAT1/STAT6/PPARγ signaling can shift the balance toward resolution.
positive regulation of microglial cell activation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| H4K12la | Alzheimer's disease | APP/PS1 mice, microglial cell lines, lactylation inhibitors |
| HMGB1/STAT3/p65 | Major depressive disorder | Chronic unpredictable stress mouse model, microglial KO of STAT3 |
| TRIM45 | Septic encephalopathy | LPS-induced sepsis model, TRIM45 knockout mice |
| NLRP3 | Ischemic stroke, pyroptosis | Middle cerebral artery occlusion (MCAO) model, NLRP3 KO mice |
| LILRB4 | Acute ischemic stroke | MCAO model, LILRB4 transgenic mice |
Alzheimer's disease
In Alzheimer's disease, positive regulation of microglial activation is driven by metabolic and epigenetic reprogramming. Histone H4 lysine 12 lactylation sustains a positive feedback loop that enhances microglial glucose metabolism and pro-inflammatory activation, contributing to disease progression. Targeting this loop may offer therapeutic benefits.
Major depressive disorder
Chronic stress induces HMGB1 release, which activates the STAT3/p65 axis in microglia, leading to increased microglial activation, autophagy, and depressive-like behaviors. This pathway represents a direct link between positive regulation of microglial activation and neuropsychiatric disease.
Septic encephalopathy and ischemic stroke
In septic encephalopathy, TRIM45 aggravates microglial pyroptosis via the Atg5/NLRP3 axis, exacerbating neuroinflammation. In ischemic stroke, microglial LILRB4 upregulation can reduce brain damage by limiting CD8+ T cell recruitment, indicating that positive regulation can sometimes be protective. Modulating microglial polarization with agents like aloe-emodin or ultrasound can reduce injury in ischemia-reperfusion models [4, 8].
From positive regulation of microglial cell activation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate microglial activation? | CRISPR knockout of gene X in BV2 or primary microglia, followed by LPS stimulation |
| Does a point mutation in gene Y alter microglial activation? | Knock-in of point mutation in mouse microglia or human iPSC-derived microglia |
| Does overexpression of gene Z enhance microglial activation? | Lentiviral overexpression in microglial cell lines or transgenic mice |
| What is the role of a specific phosphorylation site in microglial activation? | Phospho-mutant knock-in mice (e.g., STAT3 Y705F) |
| How does a risk variant affect microglial function? | CRISPR knock-in of human GWAS variant in iPSC-derived microglia |
| Can a tagged protein be used to track microglial activation? | Knock-in of fluorescent tag (e.g., GFP) into endogenous locus |
How to Study the positive regulation of microglial cell activation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify activation-associated genes in microglia |
| ChIP-seq | Histone modification and transcription factor binding | Map H4K12la or STAT3 binding sites [1, 7] |
| Proteomics | Protein abundance and interactions | Discover TRIM45-Atg5-NLRP3 complexes |
| Flow cytometry | Surface marker expression | Assess M1/M2 polarization |
| Cytokine ELISA | Secreted inflammatory mediators | Quantify microglial activation |
| Behavioral tests | Depressive-like or cognitive behaviors | Link microglial activation to phenotype |
| Immunofluorescence | Microglial morphology and marker expression | Visualize activation in brain tissue |
Transcriptomic profiling
RNA sequencing of microglia isolated from wild-type and knockout mice under basal and activated conditions can identify genes and pathways positively regulating activation. This approach has been used to uncover the HMGB1/STAT3/p65 axis in chronic stress models.
Epigenetic and proteomic analyses
Chromatin immunoprecipitation sequencing (ChIP-seq) for histone modifications such as H4K12la can reveal epigenetic drivers of microglial activation. Proteomics can identify protein-protein interactions in pathways like TRIM45-Atg5-NLRP3.
Functional assays for microglial activation
Measurements of cytokine release (e.g., TNF-α, IL-1β), phagocytosis, and oxidative burst are standard readouts. Polarization states can be assessed by flow cytometry for M1/M2 markers, as demonstrated in studies modulating STAT1/STAT6/PPARγ.
In vivo disease models
Animal models such as MCAO for stroke, LPS-induced sepsis, and chronic stress paradigms allow researchers to test the causal role of candidate genes in positive regulation of microglial activation and associated behavioral or pathological outcomes [2, 6, 7, 8].
How CRISPR Can Be Used to Study GO:1903980 positive regulation of microglial cell activation
Knockout
CRISPR knockout of candidate positive regulators (e.g., STAT3, TRIM45) in microglial cell lines or mice can determine whether they are required for microglial activation. For example, TRIM45 knockout would test its role in pyroptosis.
Point Mutation
Introducing point mutations (e.g., STAT3 Y705F) via CRISPR can dissect phosphorylation-dependent signaling in microglial activation.
Knock-in
Knock-in of disease-associated variants (e.g., in LILRB4) or tagged proteins (e.g., GFP) allows tracking and functional analysis in microglia.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can test whether increasing a gene's activity enhances microglial activation, as seen with LILRB4 upregulation.
How EDITGENE Supports positive regulation of microglial cell activation Research
Researchers studying positive regulation of microglial cell activation-related genes often need to determine whether a candidate gene is causally involved in driving microglial responses. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of microglial cell activation research.
Frequently Asked Questions About positive regulation of microglial cell activation
What is GO:1903980?
GO:1903980 is a Gene Ontology term for positive regulation of microglial cell activation, describing any process that increases the frequency, rate, or extent of microglial activation.
What genes are involved in positive regulation of microglial cell activation?
Key genes include HMGB1, STAT3, p65, TRIM45, Atg5, NLRP3, LILRB4, STAT1, STAT6, and PPARγ, as identified in recent studies [1, 2, 4, 6, 7].
How is microglial activation positively regulated in Alzheimer's disease?
In Alzheimer's disease, histone H4 lysine 12 lactylation sustains a positive feedback loop that enhances microglial glucose metabolism and pro-inflammatory activation.
What role does HMGB1 play in microglial activation?
HMGB1 activates the STAT3/p65 axis, driving microglial activation and autophagy in chronic stress-induced major depressive disorder.
Can CRISPR be used to study microglial activation?
Yes, CRISPR knockout, knock-in, and overexpression models allow precise manipulation of genes to test their causal role in microglial activation [2, 6].
What diseases are linked to positive regulation of microglial cell activation?
Alzheimer's disease, major depressive disorder, septic encephalopathy, and ischemic stroke are strongly linked [1, 2, 6, 7].
How does TRIM45 affect microglia?
TRIM45 aggravates microglial pyroptosis via the Atg5/NLRP3 axis in septic encephalopathy.
What is the role of LILRB4 in stroke?
Microglial LILRB4 upregulation reduces brain damage after acute ischemic stroke by limiting CD8+ T cell recruitment.
How can microglial polarization be modulated?
Ultrasound and pharmacological agents like aloe-emodin can shift M1/M2 polarization through STAT1/STAT6/PPARγ or NLRP3 pathways [4, 8].
What methods are used to study positive regulation of microglial activation?
Common methods include RNA-seq, ChIP-seq, proteomics, flow cytometry, cytokine assays, and in vivo disease models [1, 2, 4, 7].
Conclusion
GO:1903980, positive regulation of microglial cell activation, is a critical biological process that underlies neuroinflammation in health and disease. The integration of metabolic, epigenetic, and immune signaling pathways determines whether microglial activation is protective or pathological. Key regulators such as HMGB1, STAT3, TRIM45, and histone lactylation provide promising targets for therapeutic intervention. Continued research using CRISPR-based models and multi-omics approaches will further elucidate these mechanisms and aid in the development of precision therapies for neurological disorders.
References
- 1. Pan RY et al.. 2022. Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer's disease.. Cell Metab 34(4):634-648.e6 PMID: 35303422
- 2. Huang X et al.. 2023. TRIM45 aggravates microglia pyroptosis via Atg5/NLRP3 axis in septic encephalopathy.. J Neuroinflammation 20(1):284 PMID: 38037161
- 3. Cameron EG et al.. 2024. A molecular switch for neuroprotective astrocyte reactivity.. Nature 626(7999):574-582 PMID: 38086421
- 4. Hsu CH et al.. 2023. Ultrasound reduces inflammation by modulating M1/M2 polarization of microglia through STAT1/STAT6/PPARγ signaling pathways.. CNS Neurosci Ther 29(12):4113-4123 PMID: 37401041
- 5. Rothhammer V et al.. 2018. Microglial control of astrocytes in response to microbial metabolites.. Nature 557(7707):724-728 PMID: 29769726
- 6. Ma Y et al.. 2024. Microglia LILRB4 upregulation reduces brain damage after acute ischemic stroke by limiting CD8(+) T cell recruitment.. J Neuroinflammation 21(1):214 PMID: 39217343
- 7. Xu K et al.. 2024. HMGB1/STAT3/p65 axis drives microglial activation and autophagy exert a crucial role in chronic Stress-Induced major depressive disorder.. J Adv Res 59:79-96 PMID: 37321346
- 8. Li X et al.. 2024. Aloe-emodin alleviates cerebral ischemia-reperfusion injury by regulating microglial polarization and pyroptosis through inhibition of NLRP3 inflammasome activation.. Phytomedicine 129:155578 PMID: 38621328
